Log In
Print
BCIQ
Print
Print this Print this
 

Aldurazyme, laronidase

  Manage Alerts
Collapse Summary General Information
Company BioMarin Pharmaceutical Inc.
DescriptionRecombinant alpha-L-iduronidase
Molecular Target Lymphotoxin beta receptor (LTBR)
Mechanism of ActionEnzyme replacement therapy
Latest Stage of DevelopmentMarketed
IndicationMucopolysaccharidosis
Partner

Sanofi
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today